Newer antimicrobial agents.
D000658:Amoxicillin / Q000009:adverse effects / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002437:Cefazolin / Q000009:adverse effects / Q000627:therapeutic use; D002511:Cephalosporins / Q000627:therapeutic use; D002514:Cephapirin / Q000627:therapeutic use; D002515:Cephradine / Q000009:adverse effects / Q000627:therapeutic use; D002981:Clindamycin / Q000627:therapeutic use; D004338:Drug Combinations; D005767:Gastrointestinal Diseases / Q000188:drug therapy; D006801:Humans; D008911:Minocycline / Q000627:therapeutic use; D010406:Penicillins / Q000627:therapeutic use; D012141:Respiratory Tract Infections / Q000188:drug therapy; D012749:Sexually Transmitted Diseases / Q000188:drug therapy; D013420:Sulfamethoxazole / Q000627:therapeutic use; D014031:Tobramycin / Q000627:therapeutic use; D014295:Trimethoprim / Q000627:therapeutic use; D014552:Urinary Tract Infections / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D004338:Drug Combinations; D010406:Penicillins; D002981:Clindamycin; D000658:Amoxicillin; D002514:Cephapirin; D014295:Trimethoprim; D002515:Cephradine; D008911:Minocycline; D002437:Cefazolin; D013420:Sulfamethoxazole; D014031:Tobramycin